World Vaccine Congress Washington 2019

Research, Development And Strategic Partnering For The Global Vaccine Industry

Name: World Vaccine Congress Washington 2019
Start: 2019-04-15T08:30
End: 2019-04-17T17:00
Location: Renaissance Washington DC Downtown Hotel

April 14- 17, 2019
Renaissance Washington DC Downtown Hotel

SPONSOR NOW

FEATURED SPEAKERS

Dame Sally Davies
Chief Medical Officer
Department of Health

Michael Nally
President, Global Vaccines
Merck & Co

APPLY TO SPEAK

Dame Sally Davies

Michael Nally

SPONSORSHIP OPPORTUNITIES

1,200+

Attendees

500+

Companies

300+

Speakers

100+

Exhibitors

Conferences

Workshops

New vaccine technology is changing the whole industry

Make sure you are at the forefront of the vaccines industry. No matter where your interest lies, we have content, networking and potential partners for you.

By bringing ten events together under one roof, you get to choose the sessions which are the most applicable to help your business plan for the future of vaccine research, development and manufacture.

Take just four days out of the office to meet over 1,200+ potential customers who need to find solutions to their challenges.
Build four days of totally tailored content and attendees.

WORLD VACCINE CONGRESS WASHINGTON INCLUDES:

AGENDA OVERVIEW

"Great opportunity to network, learn of new developments and trends of the industry and obtain insights to the strategies companies are using to grow their business"

Director, GSK, United States

Scientific Advisory Board

Dr Gregory A. Poland, Director of Mayo Vaccine Research Group, Mayo Clinic and Foundation

Dr Gregory A. Poland

Director of Mayo Vaccine Research Group

Mayo Clinic

Bali Pulendran, Dpt of Pathology, Microbiology & Immunology, Stanford University School of Medicine

Prof Bali Pulendran

Department of Pathology, Microbiology & Immunology

Stanford Universty School of Medicine

Dr Bruce Gellin, President of Global Immunization, Sabin Institute

Dr Bruce Gellin

President of Global Immunization

Sabin Institute

Dr Cyril Gay, Senior National Program Leader, Office of National Programs, USDA

Dr Cyril Gay

Senior National Program Leader, Office of National Programs

USDA

Prof Stanley Plotkin, Emeritus Professor, University of Pennsylvania School of Medicine

Prof Stanley Plotkin

Emeritus Professor

University of Pennsylvania School of Medicine

Dr Peter Hotez, Dean of National School of Tropical Medicine, Baylor College of Medicine

Dr Peter Hotez

Dean of National School of Tropical Medicine

Baylor College of Medicine

Dr Paul Offit, Director of the Vaccine Education Centre, The Children’s Hospital of Philadelphia

Dr Paul Offit

Director of the Vaccine Education Centre

The Children’s Hospital of Philadelphia

Dr Roy Baynes, Senior Vice President Global Clinical Development and Chief Medical Officer, Merck

Dr Roy Baynes

Senior Vice President Global Clinical Development and Chief Medical Officer

Merck

Alessandro Sette, Center Head, Division Head, and Professor Center for Infectious Disease, La Jolla Institute

Dr Alessandro Sette

Center Head, Division Head for Infectious Disease

La Jolla Institute

Dr Ralf Clemens, SVP at GRID Rio, Advisor, Bill & Melinda Gates Foundation

Dr Ralf Clemens

SVP at GRID Rio, Advisor

Bill & Melinda Gates Foundation

Dr Walter Straus, Executive Director and Head, Scientific Affairs/ Vaccines, Merck

Dr Walter Straus

Executive Director and Head, Scientific Affairs/ Vaccines

Merck

Dr George Siber, Exec Director, CSO of ClearPath Vaccines & Chair of Scientific Advisory Board, Genocea Biosciences Inc

Dr George Siber

Exec Director, CSO of ClearPath Vaccines & Chair of Scientific Advisory Board

Genocea Biosciences Inc

Mark Davis, the Burt and Marion Avery Family Professor, Microbiology & Immunology, Stanford University

Prof Mark Davis

Professor, Microbiology & Immunology

Stanford University

Dr Leonard Friedland, VP, Scientific Affairs and Public Health Vaccines, North America, GSK

Dr Leonard Friedland

VP, Scientific Affairs and Public Health Vaccines, North America

GSK

Dr Jerald Sadoff, Senior Advisor, Janssen Infectious Diseases and Vaccines

Dr Jerald Sadoff

Senior Advisor

Janssen Infectious Diseases and Vaccines

DR HEIDI LARSON Professor of Anthropology, Risk and Decision Science London School of Hygiene and Tropical Medicine

Dr Heidi Larson

Professor of Anthropology, Risk and Decision Science

London School of Hygiene and Tropical Medicine

DR BERNARD VALLAT Former Director General World Organization For Animal Health Oie

Dr Bernard Vallat

Former Director General

World Organization For Animal Health Oie

Ofer Levy

Ofer Levy

Associate Professor of Pediatrics

Harvard Medical School

Gregory Glenn

Dr Gregory M. Glenn

MD, President
Research and Development

Novavax

Annaliesa Anderson

Dr Annaliesa Anderson

Vice President and CSO Bacterial Vaccines

Pfizer

APPLY TO SPEAK

2018 Keynote Speakers

Dr Heidi Larson
Professor of Anthropology, Risk and Decision Science
London School of Hygiene and Tropical Medicine

Dr Carl Alving
Former Chief of Adjuvant and Antigen Research & Emeritus Senior Scientist
Walter Reed Army Institute Of Research

Dr Roy Baynes
SVP of Head Global Clinical Development, Chief Medical Officer
Merck Research Laboratories
Dr Bruce Gellin
President, Global Immunization
Sabin Vaccine Institute

Ana Maria Henao Restrepo
Implementation Research and Economic Analysis, Initiative for Vaccine Research
World Health Organization

Dr Gary Nabel
Chief Scientific Officer & Senior Vice President Head, North America R&D Hub
Sanofi Pasteur
Dr Paul Offit
Chief of Infectious Diseases, & Director of the Vaccine Education Center
Childrens Hospital of Pennsylvania

Dr Walter A Orenstein
Professor and Associate Director
Emory Vaccine Center Emory University

Dr Mathuram Santosham
Professor
Johns Hopkins University
Dr Angela Shen
CAPT, US Public Health Service, Senior Science Policy Advisor, National Vaccine Program Office
U.S. Department of Health & Human Services

Dr Annaliesa Anderson
Vice President and CSO Bacterial Vaccines
Pfizer

Dr Eliav Barr
Senior Vice President, Infectious Diseases and Vaccines Clinical Development
Merck Research Laboratories
Dr Nina Bhardwaj
Director of Immunotherapy Professor of Medicine, Division of Hematology & Oncology
Tisch Cancer Institute

Dr Ezio Bonvini
CSO
MacroGenics, Inc.

Matthew Burt
Vaccine Supply Chain Director,
Pfizer
Dr Arnaud Didierlaurent
Head Adjuvant Platform
GSK Vaccines

Dr Philip Dormitzer
Vice President and CSO, Viral Vaccines
Pfizer

Dr Peter Dull
Deputy Director, Integrated Clinical Vaccine Development
The Bill & Melinda Gates Foundation
Heinz Feldmann
Chief, Laboratory of Virology Chief, Disease Modeling and Transmission Section
NIH

Geoffrey Glauser
Senior Consultant Supply Chain
HHS - ASPR - BARDA

Dr Barney Graham
Deputy Director of Vaccine Research Center
National Institute of Allergy and Infectious Diseases
Dr Duane J Gubler
Emeritus Professor, Programme in Emerging Infectious Diseases
Duke-NUS Graduate Medical School

Dr Ken Ishii
Professor and Project Leader
Osaka U.i

Dr Hector Izurieta
Epidemiologist, Immediate Office of the Director. Office of Biostatistics and Epidemiology, CBER
U.S. Federal Drug Administration
Dr Jorge Kalil
Former director of Butantan Institute, Professor and Head Clinical Immunology, School of Medicine
University Of Sao Paulo

Kemal Karaca
Director
Elanco Animal Health

Wayne C Koff
President and CEO
The Human Vaccines Project
Dr Myron M. Levine
Grollman Distinguished Professor and Director, Center for Vaccine Development
University of Maryland School of Medicine

Dr Hyam Levitsky
Executive Vice President and Chief Scientific Officer
Juno Therapeutics

Dr Ira Longini
Professor & Co-director, Center for Statistics and Quantitative Infectious Diseases (CSQUID) Emerging Pathogens Institute
University of Florida
Dr Justin R Ortiz
Former Medical Officer, Initiative for Vaccine Research for WHO & Associate Professor of Medicine
University of Maryland

Dr Viliam Pavliak
Head of Vaccine Development
International Vaccine Institute

Dr Andrew Potter
CEO
VIDO-InterVac
Dr Hari Pujar
Vice President Technical Development and Manufacturing
Moderna Therapeutics

Dr Fred Ramsdell
Vice President, Research
Parker Institute for Cancer Immunotherapy

Jeffrey Rowland
Director, Global Operational Partnerships
Gavi, The Vaccine Alliance
B.T. Slingsby
Chief Executive Officer and Executive Director
Global Health Innovative Technology Fund

Dr Jens-Ulrich Stegmann
Vice President Head Clinical Safety and Pharmacovigilance
G.S.K Biologicals

Dr Walter Straus
Associate Vice President, Therapeutic Area Head, Clinical Safety and Risk Management
Merck Research Laboratories
Dr Thomas W Scott
Distinguished Professor
University of California Davis

Laurie Werner
Director
PATH

Dr Yan-ping Yang
Senior Director, Head of Bioprocess R&D North America
Sanofi Pasteur
Darin Zehrung
Portfolio Leader of Vaccine and Pharmaceutical Delivery Technologies and Senior Technical Officer
Path

Dr Robert Zolynas
VP of R&D
Bayer Animal Health

Dr Derek O'Hagan
Global Head of Discovery Support and New Technology
GSK Vaccines

SEE ALL SPEAKERS

What some of our attendees have to say

“The totality of the experience was outstanding!”

Director of Mayo Vaccine Research Group, Mayo Clinic and Foundation

“Best vaccine conference in the world.”

CEO, Benchmark Research

“High quality presenters, mix of academia and industry, great talks, original data presented, well thought out symposia, focus on vaccines.”

VP and Director, Global Pneumococcal, Pfizer

“Excellent networking and news updates.”

Scientific Advisory Board member, Enesi Pharma Limited

"Probably the strongest conference in the vaccine sector"

Chief Executive Officer, Vaxart, United States

"This is currently the best vaccine meeting in the world, as it combines basic science, clinical product development and regulatory affairs issues with incredible networking."

Co Founder, President & CSO, Epito Genesis Inc

"Quality of the professionalism and administration of the conference by the organizers was very good. The talks and presentations were very good. The networking we achieved was very good."

VP Strategic Sales and Services, Meso Scale Diagnostics

"Extremely well organized. Good mix of time for f2f meeting, work streams and keynote speakers. High quality of talks and exhibits."

Chief Scientific Officer, Q2 Solutions

"Great opportunity to Network, Learn of new developments and trends of the industry and obtain Insights to the startegies companies are using to grow their business"

Director, GSK, United States

MISSED THE CONGRESS IN 2018? WATCH THIS & GET INSPIRED TO ATTEND IN 2019

Big Pharma and Biotechs who attend include

Aduro BioTech Inc Advaxis Agenus Altravax Amgen Arbovax Astellas Pharma Inc bioCSL Biovet Boehringer Ingelheim Ceva Animal Health ClearPath Vaccines Company Crucell Denka Seiken Co Ltd Eli Lilly & Co Emergent BioSolutions Epivax Inc Evaxion FluGen Inc G.S.K. Genocea Biosciences GeoVax Hookipa Biotech Immunomic Therapeutics Immunovaccine Inc ImmusanT Indian Immunologicals Inovio Pharmaceuticals Johnson & Johnson Mazen Animal Health MedImmune Merck & Co Merial MinervaX Nanotherapeutics Inc Newlink Genetics Novavax P.C.I. Biotech Pfizer Phibro Animal Health Prokarium Ltd Sanaria Inc Sanofi Pasteur Sinergium Biotech SynAm Vaccine Takeda Pharmaceuticals International GmbH Themis Bioscience Vaccinogen Inc Valneva Vaxart Vaxin Inc Vaxinnate Corporation VEROVACCiNES Vetmedica VitamFero Sa Zoetis